OTC Markets OTCPK - Delayed Quote USD

Terumo Corporation (TRUMY)

Compare
19.11 +0.06 (+0.31%)
As of October 29 at 4:00 PM EDT. Market Open.
Loading Chart for TRUMY
DELL
  • Previous Close 19.05
  • Open 19.05
  • Bid 19.40 x 40000
  • Ask 19.46 x 40000
  • Day's Range 19.05 - 19.05
  • 52 Week Range 13.80 - 20.59
  • Volume 1,821
  • Avg. Volume 192,939
  • Market Cap (intraday) 28.363B
  • Beta (5Y Monthly) 0.45
  • PE Ratio (TTM) 36.75
  • EPS (TTM) 0.52
  • Earnings Date Nov 7, 2024
  • Forward Dividend & Yield 0.14 (0.75%)
  • Ex-Dividend Date Mar 27, 2024
  • 1y Target Est --

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular and stent grafts. The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management and nutritious food products, adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Tokyo, Japan.

www.terumo.com

--

Full Time Employees

March 31

Fiscal Year Ends

Recent News: TRUMY

View More

Performance Overview: TRUMY

Trailing total returns as of 10/30/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

TRUMY
17.17%
Nikkei 225
17.37%

1-Year Return

TRUMY
44.88%
Nikkei 225
27.95%

3-Year Return

TRUMY
13.49%
Nikkei 225
35.94%

5-Year Return

TRUMY
17.35%
Nikkei 225
71.94%

Compare To: TRUMY

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: TRUMY

View More

Valuation Measures

Annual
As of 10/29/2024
  • Market Cap

    28.24B

  • Enterprise Value

    28.25B

  • Trailing P/E

    36.93

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.55

  • Price/Book (mrq)

    3.27

  • Enterprise Value/Revenue

    4.49

  • Enterprise Value/EBITDA

    18.08

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    12.20%

  • Return on Assets (ttm)

    5.49%

  • Return on Equity (ttm)

    8.98%

  • Revenue (ttm)

    964.81B

  • Net Income Avi to Common (ttm)

    117.72B

  • Diluted EPS (ttm)

    0.52

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    194.91B

  • Total Debt/Equity (mrq)

    16.54%

  • Levered Free Cash Flow (ttm)

    66.25B

Company Insights: TRUMY

People Also Watch